Skip to content

Pacira BioSciences

US · PCRX #3244 by market cap
36.48 0.00 0.00%
Periodic snapshot; not a real-time feed. · 2026-11-19 19:54

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Hold
Analyst consensus
Hold

All 3 views agree: neutral.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
1 4
■ Upgrades■ Downgrades
  • 1 upgrade vs 4 downgrades among tracked analyst rating changes.
  • The single most recent change was actually an upgrade (J.P. Morgan moved from Sell to Hold on 2026-10-12), though the broader window skews toward downgrades.

Analyst consensus 9 analysts

Hold
Avg price target 34.79 -4.6%
Price target rangecurrent 36.48
Low25.00
Avg34.79
High36.50
Buy 0% Hold 100% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-12 J.P. Morgan -- Hold 36.50
2026-10-09 Truist Financial -- Hold 36.50
2026-10-09 Leerink Partners -- Hold 36.50
2026-10-09 H.C. Wainwright -- Hold 36.50
2026-10-08 Jefferies -- Hold 36.00
2026-10-08 Needham -- Hold --
2026-10-08 Oppenheimer -- Hold --
2026-10-08 RBC Capital -- Hold 36.50
2026-10-07 Truist Financial -- Buy 31.00
2026-10-05 Needham -- Buy 33.00
2026-09-23 Oppenheimer -- Buy 32.00
2026-09-21 Truist Financial -- Buy --
2026-09-09 Leerink Partners -- Hold 28.00
2026-08-24 Truist Financial -- Buy --
2026-08-17 Barclays -- Hold 25.00
2026-08-10 J.P. Morgan -- Sell 23.00
2026-08-05 Needham -- Buy 33.00
2026-08-05 H.C. Wainwright -- Buy 38.00
2026-07-27 Needham -- Buy 32.00
2026-07-01 H.C. Wainwright -- Buy 38.00
2026-06-30 Needham -- Buy 32.00
2026-05-14 Barclays -- Hold 25.00
2026-05-04 H.C. Wainwright -- Buy 38.00
2026-05-01 Truist Financial -- Buy --
2026-05-01 Needham -- Buy 32.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-12 J.P. Morgan Sell → Hold 36.50
2026-10-09 Truist Financial Buy → Hold 36.50
2026-10-09 H.C. Wainwright Buy → Hold 36.50
2026-10-08 Needham Buy → Hold --
2026-10-08 Oppenheimer Buy → Hold --

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-04 After close ±10.97% -9.96% (in line)
2026/Q1 2026-04-30 After close ±12.16% -4.12% (in line)
2025/Q4 2026-02-26 After close ±13.06% -3.01% (in line)
2025/Q3 2025-11-06 After close ±16.48% +4.50% (in line)
2025/Q2 2025-08-05 After close ±11.84% -0.62% (in line)
2025/Q1 2025-05-08 After close ±12.22% +0.84% (in line)
2024/Q4 2025-02-27 After close ±14.83% -5.24% (in line)
2024/Q3 2024-11-06 After close ±13.30% +0.17% (in line)
2024/Q2 2024-07-30 After close ±36.63% +5.68% (in line)
2024/Q1 2024-05-07 After close ±12.41% +11.84% (in line)
2023/Q4 2024-02-29 -- ±14.93% -0.64% (in line)
2023/Q3 2023-11-02 -- ±7.14% +3.11% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-19 19:54:59 · For reference only, not investment advice and not tailored to your situation.

Pacira BioSciences discussion 0 comments

Add a comment